PIERANTONI, GIOVANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.238
EU - Europa 832
AS - Asia 196
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.287
Nazione #
US - Stati Uniti d'America 1.227
IT - Italia 405
CN - Cina 155
UA - Ucraina 88
IE - Irlanda 87
FI - Finlandia 60
NL - Olanda 57
SE - Svezia 52
DE - Germania 44
GB - Regno Unito 18
VN - Vietnam 16
CI - Costa d'Avorio 15
IN - India 14
FR - Francia 13
CA - Canada 11
SG - Singapore 7
ZA - Sudafrica 4
ES - Italia 2
HK - Hong Kong 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
EU - Europa 1
IL - Israele 1
MK - Macedonia 1
PK - Pakistan 1
SD - Sudan 1
Totale 2.287
Città #
Chandler 303
Napoli 107
Jacksonville 104
Princeton 62
Millbury 60
Naples 58
Amsterdam 54
Woodbridge 48
Houston 45
Nanjing 43
Ashburn 38
Beijing 37
Boston 32
Des Moines 26
Wilmington 25
Dong Ket 16
Dublin 14
Jiaxing 14
Shenyang 14
Ann Arbor 12
Boardman 12
Kronberg 12
Formia 11
Lawrence 11
Caserta 10
Ottawa 10
Nanchang 9
Salerno 8
Shanghai 8
Norwalk 7
Hebei 6
Indiana 6
Pozzuoli 6
Rome 6
Tianjin 6
Bacoli 5
Caivano 5
Kunming 5
Redwood City 5
Singapore 5
Los Angeles 4
Pune 4
Washington 4
Changsha 3
Contursi 3
Hangzhou 3
Milan 3
Parma 3
Portici 3
Sassari 3
Springs 3
Acerra 2
Altamura 2
Arienzo 2
Aversa 2
Battipaglia 2
Benevento 2
Cambridge 2
Campora 2
Changchun 2
Falls Church 2
Kowloon 2
Lappeenranta 2
Limatola 2
Portland 2
Redmond 2
Rosignano Marittimo 2
San Giorgio A Cremano 2
Seattle 2
Siderno 2
Atlanta 1
Belgrade 1
Beograd 1
Bhubaneswar 1
Boscoreale 1
Brest 1
Brussels 1
Casavatore 1
Casoria 1
Castel Campagnano 1
Castellammare di Stabia 1
Catanzaro 1
Cork 1
Delhi 1
Denver 1
Eboli 1
Edinburgh 1
Fairfield 1
Gragnano 1
Guangzhou 1
Hanover 1
Jerusalem 1
Jinan 1
Lanzhou 1
Maddaloni 1
Marcianise 1
Montréal 1
Mountain View 1
Mugnano di Napoli 1
Munich 1
Totale 1.369
Nome #
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 112
Alteration of endosomal trafficking is associated with neurodegenerative diseases 82
HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. 65
High mobility group A1 protein modulates autophagy in cancer cells. 64
Convergent effects of resveratrol and PYK2 on prostate cells 62
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs 55
Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy. 52
PERK-mediated unfolded protein response activation and oxidative stress in PARK20 fibroblasts 52
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2). 51
Effects of long-term citrate treatment in the PC3 prostate cancer cell line 50
Hmga2 is necessary for Otx2-dependent exit of embryonic stem cells from the pluripotent ground state 48
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes 47
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 44
High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. 43
Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype 43
Photodynamic and antibiotic therapy in combination to fight biofilms and resistant surface bacterial infections 43
Neoplastic transformation of rat thyroid cells requires the JunB and Fra1 gene induction which is dependent on the HMGI-C gene products. 41
Rnf4 is a growth inhibitor expressed in germ cells but not in human testicular tumors 41
Critical role of the HMGA2 gene in pituitary adenomas. 41
Prognostic significance of N-cadherin expression in oral squamous cell carcinoma. 41
Lithium chloride increases sensitivity to photon irradiation treatment in primary mesenchymal colon cancer cells 40
Nrf2 pathway in age-related neurological disorders: Insights into MicroRNAs 38
FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. 37
Effects of Resveratrol on p66Shc phosphorylation in cultured prostate cells 37
HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity 35
Hmga1 null mouse embryonic fibroblasts display downregulation of spindle assembly checkpoint gene expression associated to nuclear and karyotypic abnormalities 35
A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas. 34
Phenotypic effects of homeodomain-interacting protein kinase 2 deletion in mice 34
Transforming properties of Felis catus papillomavirus type 2 E6 and E7 putative oncogenes in vitro and their transcriptional activity in feline squamous cell carcinoma in vivo 33
Mitochondrial malfunctioning, proteasome arrest and apoptosis in cancer cells by focused intracellular generation of oxygen radicals 33
HMGA1 protein is a novel target of the ATM kinase. 32
PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context. 32
Regulation of HIPK Proteins by MicroRNAs 32
Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs 32
E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression. 31
Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2. 31
Cell-penetrating peptides: two faces of the same coin 31
Thyroid cell transformation requires the expression of the HMGA1 proteins 30
Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement. 30
Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. 29
Interplay between steroid receptors and neoplastic progression in sarcoma tumors. 29
Cytokines and VEGF induction in orthodontic movement in animal models. 29
Double knock-out of Hmga1 and Hipk2 genes causes perinatal death associated to respiratory distress and thyroid abnormalities in mice 29
Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT Cells 28
Analysis of UbcH10 expression represents a useful tool for the diagnosis and therapy of astrocytic tumors. 26
Pit-1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. 26
p53 suppresses the Nrf2-dependent transcription of antioxidant response genes 25
Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours. 24
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. 23
Pax8 has a critical role in epithelial cell survival and proliferation 23
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane. 22
Thymosin beta-10 gene expression as a possible tool in diagnosis of thyroid neoplasias. 22
High-mobility group A1 proteins are overexpressed in human leukaemias. 21
CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1. 21
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells 21
The high mobility group A2 gene is amplified and overexpressed in human prolactinomas 20
HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. 20
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. 20
HIPK2 in cancer biology and therapy: Recent findings and future perspectives 19
Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. 19
The Genetics of Pituitary Adenomas 19
The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues 18
Phloroglucinol-Derived Medications are Effective in Reducing Pain and Spasms of Urinary and Biliary Tracts: Results of Phase 3 Multicentre, Open-Label, Randomized, Comparative Studies of Clinical Effectiveness and Safety 17
Down Syndrome Fetal Fibroblasts Display Alterations of Endosomal Trafficking Possibly due to SYNJ1 Overexpression 17
Comprehensive conventional and molecular cytogenetic characterization of B-CPAP, a human papillary thyroid carcinoma-derived cell line. 17
Deregulation of microRNA expression in thyroid neoplasias 17
Chronic exposure to l-BMAA cyanotoxin induces cytoplasmic TDP-43 accumulation and glial activation, reproducing an amyotrophic lateral sclerosis-like phenotype in mice 16
High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. 16
Anti-VEGF therapy in breast and lung mouse models of cancers 16
Impairment of the p27KIP1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice. 15
Glix 13, a New Drug Acting on Glutamatergic Pathways in Children and Animal Models of Autism Spectrum Disorders 15
Anti-VEGF therapy in breast and lung mouse models of cancers. 15
HIPK2 Controls Cytokinesis and Prevents Tetraploidization by Phosphorylating Histone H2B at the Midbody. 14
Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype 14
High mobility group A-interacting proteins in cancer: focus on chromobox protein homolog 7, homeodomain interactin protein kinase 2 and PATZ 13
Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. 11
HMGA1 and HMGA2 protein expression in mouse spermatogenesis. 11
HIPK2 in the physiology of nervous system and its implications in neurological disorders 3
Totale 2.474
Categoria #
all - tutte 8.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.986


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 5 1 6
2019/2020286 88 1 27 22 48 10 7 3 1 24 26 29
2020/2021298 8 25 50 29 28 41 19 7 33 6 32 20
2021/2022413 11 3 0 9 12 8 5 9 74 32 104 146
2022/2023664 84 73 27 75 67 73 9 55 96 54 41 10
2023/2024284 16 67 70 26 15 27 10 32 9 12 0 0
Totale 2.474